Sadikin informed that abolition of the provision was stipulated in Health Ministerial Regulation No. 23 of 2021 on the third amendment to Regulation of the Minister of Health No. 10 of 2021 concerning the implementation of vaccination in the framework of countering the COVID-19 pandemic.
"With this change, the implementation of COVID-19 vaccination remains the same as the earlier process. The vaccine is given free to all Indonesians through the National COVID-19 Vaccination Program by the government, and the Gotong Royong Vaccination Program by (private) companies," Sadikin stated in a ministry’s press release received here on Monday.
The provisions on paid vaccination services for individuals in the Gotong Royong vaccination scheme are stipulated in Ministerial Regulation No. 19 of 2021 on the second amendment to Ministerial Regulation No. 10 of 2021 concerning the implementation of vaccination in the framework of countering the COVID-19 pandemic, he expounded.
Citing the new provisions of the Gotong Royong vaccination services by the company, Sadikin clarified that they only administered the Sinopharm vaccine.
Related news: Indonesia sets Sinopharm complete vaccination price at Rp879,140
"The Gotong Royong vaccination has a target to cover about 7.5 million people over the age of 18," he stated.
Meanwhile, Sadikin noted that the National COVID-19 Vaccination Program had targeted over 200 million Indonesians, and the government had administered vaccines of Sinovac, AstraZeneca, Moderna, Pfizer, Sinopharm, and Novavax .
Furthermore, the Indonesian Health Ministry’s spokesperson for COVID-19 Vaccination Program Siti Nadia Tarmizi made assurance of sufficient vaccine stocks to meet the regional demand.
"We have adequate stocks of vaccine. However, please note that all targets cannot be vaccinated simultaneously, as vaccine doses also arrive gradually," Tarmizi stated here on August 5, 2021.
According to the Ministry of Communication and Informatics’ (Kominfo’s) data, until August 3, 2021, Indonesia had received 179 million vaccine doses comprising 144.7 million doses of bulk vaccine and 34.7 million doses of ready-to-use vaccine. Related news: Kimia Farma decides to postpone paid vaccination drive